Quince Therapeutics, Inc.
QNCX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662774
No open-market purchases or sales by Quince Therapeutics, Inc. insiders were filed in the last 90 days; 26 institutions reported holding it in 13F filings for Q2 2026, worth $4.74M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Quince Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +2 vs. Q2 2023
- Shares held
- 7.50M
- −1.47M (−16.4%) vs. Q2 2023
- Total value
- $8.40M
- −$5.11M (−37.8%) vs. Q2 2023
- New holders
- 4
- 9 more added
- Sold out
- 2
- 8 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting QNCX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 26 | $4.74M |
| Q1 2026 | 46 | $1.44M |
| Q4 2025 | 67 | $67.5M |
| Q3 2025 | 45 | $19.2M |
| Q2 2025 | 41 | $12.5M |
| Q1 2025 | 36 | $6.96M |
| Q4 2024 | 35 | $9.55M |
| Q3 2024 | 33 | $4.04M |
| Q2 2024 | 43 | $4.68M |
| Q1 2024 | 46 | $7.71M |
| Q4 2023 | 44 | $7.83M |
| Q3 2023 | 42 | $8.40M |
| Q2 2023 | 40 | $13.5M |
| Q1 2023 | 45 | $12.0M |
| Q4 2022 | 50 | $3.44M |
| Q3 2022 | 61 | $12.4M |
| Q2 2022 | 70 | $26.0M |
| Q1 2022 | 88 | $99.5M |
| Q4 2021 | 102 | $242.8M |
| Q3 2021 | 131 | $1.76B |
| Q2 2021 | 105 | $982.9M |
| Q1 2021 | 91 | $673.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Quince Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Tang Capital Management LLC | 3,498,868 | $3.92M | 0.55% | −114,412−3.2% | Reduced |
| Vanguard Group Inc | 949,991 | $1.06M | 0.00% | +56,700+6.3% | Added |
| EPIQ Capital Group, LLC | 926,500 | $1.04M | 0.56% | −6,680−0.7% | Reduced |
| BlackRock Inc. | 336,442 | $376.8K | 0.00% | −3,273−1.0% | Reduced |
| Renaissance Technologies LLC | 325,000 | $364.0K | 0.00% | +36,300+12.6% | Added |
| Geode Capital Management, LLC | 219,603 | $246.0K | 0.00% | +32,441+17.3% | Added |
| Alphabet Inc. | 189,122 | $211.8K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 172,962 | $193.7K | 0.00% | +10,023+6.2% | Added |
| Bridgeway Capital Management, LLC | 138,495 | $155.1K | 0.00% | +83,495+151.8% | Added |
| Two Sigma Advisers, LP | 131,900 | $147.7K | 0.00% | −59,289−31.0% | Reduced |
| Susquehanna International Group, LLP | 103,982 | $116.5K | 0.00% | −8,790−7.8% | Reduced |
| Jane Street Group, LLC | 75,885 | $85.0K | 0.00% | +75,885 | New |
| Mariner, LLC | 75,079 | $84.1K | 0.00% | +75,079 | New |
| Millennium Management LLC | 59,928 | $67.1K | 0.00% | −1,479−2.4% | Reduced |
| State Street Corp | 56,611 | $63.4K | 0.00% | 00.0% | Unchanged |
| Intellectus Partners, LLC | 53,527 | $60.0K | 0.02% | 00.0% | Unchanged |
| Northern Trust Corp | 43,858 | $49.1K | 0.00% | 00.0% | Unchanged |
| XTX Topco Ltd | 31,940 | $35.8K | 0.01% | +31,940 | New |
| Two Sigma Investments, LP | 19,645 | $22.0K | 0.00% | −49,884−71.7% | Reduced |
| Strategic Blueprint, LLC | 12,200 | $13.7K | 0.00% | 00.0% | Unchanged |
| Cohen Lawrence B | 11,126 | $12.5K | 0.01% | 00.0% | Unchanged |
| Charles Schwab Investment Management Inc | 11,013 | $12.3K | 0.00% | 00.0% | Unchanged |
| Westmount Partners, LLC | 10,148 | $11.4K | 0.01% | 00.0% | Unchanged |
| Brinker Capital Investments, LLC | 10,136 | $11.4K | 0.00% | 00.0% | Unchanged |
| Orion Portfolio Solutions, LLC | 10,136 | $11.4K | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 9,542 | $10.7K | 0.00% | +2,293+31.6% | Added |
| UBS Group AG | 6,668 | $7.47K | 0.00% | +5,756+631.1% | Added |
| Citigroup Inc | 5,165 | $5.79K | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 2,376 | $2.66K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,212 | $1.36K | 0.00% | +1,058+687.0% | Added |
| JPMorgan Chase & Co | 469 | $525 | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 394 | $441 | 0.00% | 00.0% | Unchanged |
| JDM Financial Group LLC | 340 | $381 | 0.00% | 00.0% | Unchanged |
| Financial Perspectives, Inc | 310 | $347 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 277 | $310 | 0.00% | 00.0% | Unchanged |
| Allworth Financial LP | 267 | $300 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 200 | $224 | 0.00% | +100+100.0% | Added |
| Financial Avengers, Inc. | 100 | $112 | 0.00% | 00.0% | Unchanged |
| Householder Group Estate & Retirement Specialist, LLC | 100 | $112 | 0.00% | +100 | New |
| Westside Investment Management, Inc. | 75 | $84 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 59 | $66 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 137 | $0 | 0.00% | −341−71.3% | Reduced |
| BML Capital Management, LLC | 0 | $0 | 0.00% | −1,411,839−100.0% | Sold out |
| Knightsbridge Asset Management, LLC | 0 | $0 | 0.00% | −228,605−100.0% | Sold out |